ConductScience.org, home

Paper40116625

Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future.

Hassanein A and 1 other. Biomol Biomed, 2025. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future. Papers, record 40116625. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40116625

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent advances in stem cell-based therapies for type 1 diabetes: A glimpse into the future.
PubMed
Journal
Biomol Biomed
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
2.88, provisional
iCite
Revised in PubMed
2025-10-08
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hassanein AAhmed
2Akhtar SSaghir

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 1Major topic
Stem Cell TransplantationMajor topic
Stem CellsMajor topic
Humans
Insulin-Secreting Cells
Animals

References128

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131180194An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.N Engl J Med2019https://conductscience.org/library/papers/31180194PubMed
227525644Effects of Composition of Alginate-Polyethylene Glycol Microcapsules and Transplant Site on Encapsulated Islet Graft Outcomes in Mice.Transplantation2017https://conductscience.org/library/papers/27525644PubMed
321205883Genetics of type 1 diabetes.Clin Chem2011https://conductscience.org/library/papers/21205883PubMed
431850335Cell Encapsulation Within Alginate Microcapsules: Immunological Challenges and Outlook.Front Bioeng Biotechnol2019https://conductscience.org/library/papers/31850335PubMed
535255603Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors.Endocrinol Metab (Seoul)2022https://conductscience.org/library/papers/35255603PubMed
638360355Encapsulation and immune protection for type 1 diabetes cell therapy.Adv Drug Deliv Rev2024https://conductscience.org/library/papers/38360355PubMed
733990318An inverse-breathing encapsulation system for cell delivery.Sci Adv2021https://conductscience.org/library/papers/33990318PubMed
833277608Engineering precision nanoparticles for drug delivery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33277608PubMed
934959358Assessing the Effects of VEGF Releasing Microspheres on the Angiogenic and Foreign Body Response to a 3D Printed Silicone-Based Macroencapsulation Device.Pharmaceutics2021https://conductscience.org/library/papers/34959358PubMed
1019583810The immune boundaries for stem cell based therapies: problems and prospective solutions.J Cell Mol Med2009https://conductscience.org/library/papers/19583810PubMed
1139595139Alginate-Poly[2-(methacryloyloxy)ethyl]trimethylammonium Chloride (PMETAC) Immunoisolating Capsules Prolong the Viability of Pancreatic Islets In Vivo.Biomedicines2024https://conductscience.org/library/papers/39595139PubMed
1233083260Current Perspective on Auto-antibodies in Type 1 Diabetes.Indian J Endocrinol Metab2020https://conductscience.org/library/papers/33083260PubMed
1336731781Localized cytotoxic T cell-associated antigen 4 and antioxidant islet encapsulation alters macrophage signaling and induces regulatory and anergic T cells to enhance allograft survival.Am J Transplant2023https://conductscience.org/library/papers/36731781PubMed
1437156915Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques.Nat Biotechnol2024https://conductscience.org/library/papers/37156915PubMed
1537043559Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice.Sci Transl Med2023https://conductscience.org/library/papers/37043559PubMed
1632080339Small-molecule-mediated reprogramming: a silver lining for regenerative medicine.Exp Mol Med2020https://conductscience.org/library/papers/32080339PubMed
1718991254Optimal implantation site for pancreatic islet transplantation.Br J Surg2008https://conductscience.org/library/papers/18991254PubMed
1822233865Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells.BMC Med2012https://conductscience.org/library/papers/22233865PubMed
1937712342
Short-term function and immune-protection of microencapsulated adult porcine islets with alginate incorporating CXCL12 in healthy and diabetic non-human primates without systemic immune suppression: A pilot study.
Xenotransplantation2023https://conductscience.org/library/papers/37712342PubMed
2016904174Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell2006https://conductscience.org/library/papers/16904174PubMed

See all 128 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42972590Emerging molecular and cellular therapeutics for type 2 diabetes: integrating stem cell and miRNA approaches toward precision medicine.Stem Cell Res Ther2026https://conductscience.org/library/papers/42972590PubMed
42897562The role of the epidermal growth factor receptor (EGFR/ErbB1) in diabetic retinopathy and its therapeutic implications.J Transl Med2026https://conductscience.org/library/papers/42897562PubMed
42756827Precision Genome Engineering in Human Disease: Expanding Therapeutic Roles of CRISPR Technologies.Niger Med J2026https://conductscience.org/library/papers/42756827PubMed
42542743Cell-Based Therapies for Type 1 Diabetes: A Narrative Review of Stem Cell-Derived Islets, Encapsulation Strategies, and Recent Clinical Trials.Cureus2026https://conductscience.org/library/papers/42542743PubMed
42353029Metagenomic Insights into Gut Microbiota Alterations Following Dendrobium huoshanense Water Extract Intervention in Streptozotocin-Induced Type 1 Diabetic Rats.Int J Mol Sci2026https://conductscience.org/library/papers/42353029PubMed
42104727Stem cell-based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection.Animal Model Exp Med2026https://conductscience.org/library/papers/42104727PubMed
41379378Vav1 Sustains the Expression of Insulin, PDX1 and miR-375 During Differentiation of hiPSCs to β Cells: A Potential Target to Improve the In Vitro Generation of Insulin-Producing Cells.Tissue Eng Regen Med2026https://conductscience.org/library/papers/41379378PubMed
40428118Assessing Implantation Sites for Pancreatic Islet Cell Transplantation: Implications for Type 1 Diabetes Mellitus Treatment.Bioengineering (Basel)2025https://conductscience.org/library/papers/40428118PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40116625

GET https://conductscience.org/api/papers/v1/40116625/references?page=2